APIs per la ricerca e le impurità

7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one is an analytical reference standard for HPLC. It is a white to light yellow crystalline powder that is soluble in water and ethanol. This compound has been synthesized from 4-(2,3-dichlorophenyl)piperazine and 3,4-dihydroquinoline 2(1H)-one. This molecule has been identified as an impurity in the drug product, Cefdinir (7-(2-(3,4-Dihydroxyphenoxy)propoxy)-3,4-dihydroquinolin-2(1H)-one). The purity of this chemical has been shown to be greater than 99.5% by high performance liquid chromatography (HPLC).

Desoxyquinocetone is a specific antibody that recognizes and binds to the quinoline ring of desoxyquinocetone. It has low bioavailability in the body, which is determined by the structural formula. The detection sensitivity of this antibody is high, and it can be used in tissue samples. This antibody also has a chromatographic method for determining carbonyl reduction and a monoclonal antibody for hybridoma cell strain. The specificity of this antibody is determined by the target tissue and strain, as well as its chromatographic method for detecting antigen.

Please enquire for more information about 6-Hydroxy-4’-tert-butyldimethylsylyl raloxifene-d4 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Lamivudine is an antiviral drug that belongs to the group of nucleoside analogues. It is a prodrug that is activated by intracellular phosphorylation to form the active compound, lamivudine triphosphate (L-TTP). L-TTP inhibits viral replication by competing with natural substrates for incorporation into viral DNA. The antiviral activity of L-TTP has been shown in animals and humans with hepatitis B virus or human immunodeficiency virus type 1 (HIV-1) infections. Lamivudine S-oxide is a stereoselective form of lamivudine, which can be used for chemoprophylaxis against the pandemic H1N1 virus. This drug has shown to have a lower toxicity profile than other drugs used for this purpose.

Lansoprazole impurity H is a metabolite of lansoprazole, a proton pump inhibitor that inhibits the production of stomach acid. Lansoprazole impurity H is used in research and development as an analytical standard to measure lansoprazole concentrations in drug products. It is also used as an impurity standard for pharmacopoeia purposes. Lansoprazole impurity H is not known to be toxic, but it has not been evaluated for carcinogenicity or reproductive toxicity.

2-Methoxy-5-methyl-gamma-phenylbenzenepropanol is a synthetic compound that is used as an intermediate in the synthesis of coumarin derivatives. Reaction with sulfonating agents produces sulfones, and reaction with borohydride reagents produces boronates. The synthesis of 2-methoxy-5-methyl-gamma-phenylbenzenepropanol can be accomplished by the reduction of diphenyl ethers with lithium aluminum hydride or borohydride. The reduction can also be carried out using lanthanum oxide and potassium borohydride. The reaction proceeds smoothly at room temperature in nonpolar solvents.
2-Methoxy-5-methyl-gamma-phenylbenzenepropanol reacts with chloride to produce the corresponding chlorides, which are useful intermediates for the synthesis of tolterodine tartrate, a drug used to treat urinary inc

DMAC-PDB is an aromatic cleavable linker commonly used in protein and drug conjugation. It enables controlled release of payloads under specific chemical conditions.

Enrofloxacin impurity C is an impurity of enrofloxacin, a drug product. It is a metabolite of enrofloxacin, which has been studied for its effects on the metabolism and pharmacokinetics of this drug. Enrofloxacin impurity C specifically inhibits the activity of CYP3A4 and CYP2C8 in vitro. Enrofloxacin impurity C also has been shown to have niche applications in analytical chemistry as an impurity standard for HPLC analyses.

Please enquire for more information about Efavirenz-d5 including the price, delivery time and more detailed product information at the technical inquiry form on this page

Ribosamine is a medicinal compound that has shown potential as an anticancer agent. It is a kinase inhibitor that targets specific proteins involved in cancer cell growth and survival. Ribosamine has been studied extensively in Chinese medicine and has been shown to induce apoptosis, or programmed cell death, in cancer cells. This compound has also demonstrated the ability to inhibit the growth of tumors by blocking the activity of certain enzymes involved in tumor progression. Ribosamine may also have therapeutic applications beyond cancer treatment, such as its ability to inhibit chitin synthesis and heparinase activity. Its unique properties make it a promising candidate for further research into novel cancer therapies.

Please enquire for more information about Evixapodlin including the price, delivery time and more detailed product information at the technical inquiry form on this page

(-)-Neoisomenthol is a drug product that is a natural product and is found in peppermint oil. It has been shown to have anti-inflammatory and analgesic properties. (-)-Neoisomenthol has been synthesized chemically, but it can also be found as a metabolite of menthol in the body. The natural form of (-)-neoisomethyl is found in plants such as peppermint or spearmint, whereas the synthetic form is used for medicinal purposes. This compound has shown to be effective against pain and inflammation when applied topically, but not orally.

N-Acetyl-S-(2-carboxypropyl)-L-cysteine disodium salt is an analog of a human kinase inhibitor that has been shown to inhibit cyclin-dependent kinases. This compound induces apoptosis in cancer cells and has been tested in Chinese hamster ovary cells. N-Acetyl-S-(2-carboxypropyl)-L-cysteine disodium salt is a potent anticancer agent that inhibits the growth of tumor cells by blocking protein synthesis. It has been used as a research tool to study the effects of kinase inhibitors on cancer cell growth and may have potential therapeutic applications in cancer treatment. The compound has also been detected in human urine and may serve as a biomarker for the presence of certain types of cancer.

4-Chloroestradiol is a synthetic, natural, and drug development metabolite. It is a highly pure and analytical drug product with a niche in the market. This compound has been shown to inhibit proliferation of breast cancer cells in vitro. 4-Chloroestradiol is not currently used as a therapeutical agent but may be used for research and development purposes. The metabolite is also known to have anti-inflammatory activities, which are due to its ability to reduce prostaglandin synthesis.

Liotrix is a drug that acts as an inhibitor of apoptosis and has been shown to have anticancer properties. It is derived from Chinese urine and works by inhibiting kinase activity, which is essential for the survival of cancer cells. Liotrix is an analog of quetiapine, a drug used to treat schizophrenia and bipolar disorder, and has been found to be effective against various types of tumors in human cancer cell lines. This drug specifically targets kinases, which are enzymes involved in the regulation of cellular processes such as growth and differentiation. By inhibiting these kinases, Liotrix can prevent the proliferation and survival of cancer cells, making it a promising candidate for the treatment of various forms of cancer.

D-Ribose-3-D is a medicinal compound that has been shown to have anti-cancer properties. It is an inhibitor of kinases, which are enzymes that play a critical role in cancer cell growth and proliferation. D-Ribose-3-D has been found to inhibit the growth of human cancer cells and induce apoptosis, or programmed cell death, in these cells. This compound has also been studied for its potential use as an anticancer drug and has shown promising results in Chinese hamster ovary cells. Additionally, D-Ribose-3-D has been investigated for its potential use as an inhibitor of acetylcholinesterase, the enzyme targeted by donepezil in the treatment of Alzheimer's disease. Overall, D-Ribose-3-D holds great promise as a potent and effective medicinal compound with a wide range of potential applications.

NUC-7738 is a medicinal compound that has been shown to be an effective inhibitor of cyclin-dependent kinases (CDKs). It has potent anticancer activity and has been studied extensively in Chinese hamster ovary (CHO) cells, human leukemia cells, and other cancer cell lines. NUC-7738 works by selectively inhibiting CDK4/6, which are critical regulators of the cell cycle. This leads to the induction of apoptosis in cancer cells, making it a promising new therapeutic agent for the treatment of various types of cancer. Additionally, NUC-7738 has been shown to have low toxicity and good pharmacokinetic properties in preclinical studies. Overall, this compound holds great promise as a novel anticancer therapy that may help improve outcomes for patients with cancer.

(2S,2S,Trans)-saxagliptin is a drug product that has been developed as an oral anti-diabetic agent. It is a synthetic compound with the chemical name of (2S,2S,Trans)-4-[(1R)-1-[[(3Z)-3-(dimethylamino)-1-[(4-methylphenyl)sulfonyl]propanoyl]amino]-2-methylpropyl]-N-[4-(6-methoxy-3-pyridinyl)benzoyl]glycine. The synthesis of this drug is based on the natural amino acid sequence of the human insulin molecule. (2S,2S,Trans)-saxagliptin has been shown to be metabolized in vivo through hydroxylation and glucuronidation pathways and to have a half life of approximately 10 hours in humans. This drug product is intended for research and development purposes only

2,2-Bis[4-(2-diethylaminoethoxy)phenyl]-1,2-diphenylethanone (bis-DEA) is a synthetic metabolite that has been shown to inhibit human liver microsomal cytochrome P450 enzymes. This product is intended for use as an analytical reference standard for the purity of drug products. It is also used in pharmacological and metabolic studies.

Rabeprazole Impurity 2 is a research and development impurity standard that is used for qualitative analysis. It can be custom synthesized to meet specific needs, and it can also be used in drug product synthesis. Rabeprazole Impurity 2 is a high purity synthetic compound that has been pharmacopoeia-qualified. It can also be used as a metabolite or analytical standard, and it has been studied for its metabolism studies with HPLC-MS. Rabeprazole Impurity 2 has CAS No. 1807988-36-8.

6-Iodo-2-propoxy-3-propylquinazolin-4(3H)-one is a potent anticancer agent that inhibits the activity of specific kinases involved in cancer cell growth and proliferation. It has been shown to induce apoptosis, or programmed cell death, in cancer cells by blocking the activity of certain proteins. This compound is structurally similar to other kinase inhibitors used in medicinal chemistry, such as gefitinib and erlotinib. 6-Iodo-2-propoxy-3-propylquinazolin-4(3H)-one has been tested on human and Chinese hamster ovarian cells and has demonstrated significant antitumor activity. It is a promising candidate for the development of new cancer therapies due to its potent inhibitory effects on kinases involved in tumor growth and progression. Additionally, this chemical analog can be detected in urine samples, making it a useful tool for studying kinase activities in vivo.

WH-4-025 is a potent kinase inhibitor that has shown promising results in the treatment of various cancers. It is derived from Chinese medicinal herbs and has been extensively studied for its anticancer properties. WH-4-025 works by inhibiting the activity of specific kinases that are involved in tumor growth and cell cycle regulation. It has been shown to induce apoptosis in cancer cells, leading to their death, and also inhibit the growth of leukemia cells. This protein inhibitor has been found to be effective against a wide range of human cancers and is currently being investigated as a potential therapy for cancer patients. WH-4-025 is excreted through urine, making it an attractive candidate for further development as an anticancer drug.